Technology
Health
Medical

Heska

$77.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.29 (-0.37%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Heska and other stocks, options, ETFs, and crypto commission-free!

About

Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through two segments: Core Companion Animal Health and Other Vaccines & Pharmaceuticals. Read More The Core Companion Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines. The Other Vaccines & Pharmaceuticals segment focuses on private label vaccine and pharmaceutical production, primarily for cattle, but also for equine, porcine, avian, feline, and canine. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

Employees
347
Headquarters
Loveland, Colorado
Founded
1988
Market Cap
603.00M
Price-Earnings Ratio
141.40
Dividend Yield
0.00
Average Volume
57.07K
High Today
$78.24
Low Today
$76.58
Open Price
$77.76
Volume
15.85K
52 Week High
$114.50
52 Week Low
$71.50

Collections

Technology
Health
Medical
Software Service
Pharmaceutical
US
North America

News

Seeking AlphaMay 10

Heska Corporation CEO Kevin Wilson on Q1 2019 Results - Earnings Call Transcript

Heska Corporation (NASDAQ:HSKA) Q1 2019 Earnings Conference Call May 7, 2019 11:00 AM ET Company Participants Jon Aagaard - Director-Investor Relations Catherine Grassman - Chief Accounting Officer Kevin Wilson - Chief Executive Officer and President Jason Napolitano - Chief Operating Officer and Chief Strategist Conference Call Participants Mark Massaro - Canaccord Genuity Limited Benjamin Haynor - Alliance Global Partners Andrew Cooper - Raymond James Bruce Jackson - The Benchmark Company David...

3
PR NewswireMay 7

Heska Corporation Reports First Quarter 2019 Results

LOVELAND, Colo., May 7, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, today reported financial results for its first quarter ended March 31, 2019. The Company reports results in two segments: Core Companion Animal ("CCA") and Other Vaccines & Pharmaceuticals ("OVP"). Point of Care is referred to in this release as "POC". The Company forecast for 2019 from the February 26, 2019 earnings call and rel...

2
Seeking AlphaMay 6

New finance chief at Heska

0

Earnings

-$0.09
$0.19
$0.48
$0.76
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.09 per share
Actual
-$0.03 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.